Reference is made to the stock exchange announcement made on 6 June 2023 regarding Nordic Nanoctor ASA's ("Nordic c Nanovector") contemplated acquisition of all the issued and outstanding shares in Thor Medical AS (the "Transaction"), and the stock exchange announcement on 28 June regarding the approval of the Transaction by the Company's annual general meeting. Additionally, Brede Ellingsæter has assumed the position as CFO of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.038 NOK | -3.17% | -1.70% | -19.53% |
28/02 | Transcript : Thor Medical ASA, H2 2023 Earnings Call, Feb 28, 2024 | |
14/02 | Thor Medical ASA Announces CEO Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-19.53% | 22.48M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- NANOV Stock
- News Thor Medical
- Nordic Nanovector ASA Appoints Brede Ellingsæter as CFO